Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
V Paspalj, Stephan Polterauer, Nina Poetsch, Alexander Reinthaller, Christoph Grimm, Thomas Bartl
Abstract
•Checkpoint inhibitor therapy affecting PD-L1 as treatment for advanced solid tumors.•Success in trial pembrolizumab therapy in multiresistant metastatic choriocarcinoma.•Long-term remission after pembrolizumab therapy in multiresistant choriocarcinoma.•Only six reported cases, one with comparable follow-up and outcome.
Topics & Concepts
PembrolizumabMedicineChoriocarcinomaOncologyInternal medicineImmunotherapyCancerGestational Trophoblastic Disease StudiesLung Cancer Research StudiesChromatin Remodeling and Cancer